Texas Cancer Agency Unshackled

Texas’s top officials have authorized the state's troubled cancer research institute to award $71.8 million in recruitment grants that have been on hold since last December.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Texas State Capitol, AustinWIKIMEDIA, STUART SEEGERState leaders have granted permission for Texas’s embattled $3 billion cancer research agency to award 25 researcher recruitment grants that have been withheld due to concerns over how the grants were reviewed, reported ScienceInsider.

Yesterday’s announcement is a welcome piece of positive news for the state-funded Cancer Prevention and Research Institute of Texas (CPRIT), which has faced controversy over allegations of improper scientific review and political influence for the best part of year.

CPRIT’s troubles became public last May, when then-Chief Scientific Officer Alfred Gilman announced his resignation, citing concerns about the review of an $18 million research grant. By October, all 8 members of the scientific review council, along with roughly 100 peer reviewers, had also resigned. In December, following a recommendation by Governor Rick Perry, CPRIT imposed a moratorium on new grants until concerns had been addressed and confidence restored.

A state audit released this January found that CPRIT had awarded a total of $56.4 million in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies